Technical Platforms

We build a world-class pipeline by proprietary discovery platforms. Our innovation engine has been validated by clinical assets and global partnerships.

Get in Touch →

You are here: Home » The Synergy of H3 Discovery Platform + HuIgG

The Synergy of H³ Discovery Platform + HuIgG

Transgenic Mouse for Fast Generation of Best-in-Class Fully Human mAb as Building Block for Bispecifics

H³ Antibody Discovery Platform

High-throughput

Generates a large hybridoma pool for superior leads identification

15-25x higher than industry average (1000~5000 antigen-positive hybridomas per project)

High-content

Multiple parameter screening simultaneously - specificity, cross reactivity, affinity, epitope grouping, bioactivity

High-efficiency

Identifying lead candidates with maximized ROI 2~10x higher than industry average

Antibody Discovery - Case Study

Find us in China, Hong Kong SAR, the United States & Australia

Quick Links